Giant Health Events Ltd. - Period Ending 2021-03-31

Giant Health Events Ltd. - Period Ending 2021-03-31


Giant Health Events Ltd. 10063388 false 2020-04-01 2021-03-31 2021-03-31 The principal activity of the company is Activities of conference organisers Digita Accounts Production Advanced 6.29.9459.0 true 10063388 2020-04-01 2021-03-31 10063388 2021-03-31 10063388 core:CurrentFinancialInstruments 2021-03-31 10063388 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 10063388 core:FurnitureFittingsToolsEquipment 2021-03-31 10063388 bus:SmallEntities 2020-04-01 2021-03-31 10063388 bus:AuditExemptWithAccountantsReport 2020-04-01 2021-03-31 10063388 bus:FullAccounts 2020-04-01 2021-03-31 10063388 bus:SmallCompaniesRegimeForAccounts 2020-04-01 2021-03-31 10063388 bus:RegisteredOffice 2020-04-01 2021-03-31 10063388 bus:Director1 2020-04-01 2021-03-31 10063388 bus:Director2 2020-04-01 2021-03-31 10063388 bus:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31 10063388 core:FurnitureFittingsToolsEquipment 2020-04-01 2021-03-31 10063388 core:OfficeEquipment 2020-04-01 2021-03-31 10063388 core:OtherRelatedParties 2020-04-01 2021-03-31 10063388 countries:AllCountries 2020-04-01 2021-03-31 10063388 2020-03-31 10063388 core:FurnitureFittingsToolsEquipment 2020-03-31 10063388 2019-04-01 2020-03-31 10063388 2020-03-31 10063388 core:CurrentFinancialInstruments 2020-03-31 10063388 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 10063388 core:FurnitureFittingsToolsEquipment 2020-03-31 iso4217:GBP xbrli:pure

Registration number: 10063388

Giant Health Events Ltd.

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2021

 

Giant Health Events Ltd.

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

Giant Health Events Ltd.

Company Information

Directors

Mr Barry Shrier

Mr Olivett Asare

Registered office

GIANT Health
Health Foundry
1 Royal Street
London
SE1 7LL

 

Giant Health Events Ltd.

(Registration number: 10063388)
Balance Sheet as at 31 March 2021

Note

2021
£

2020
£

Fixed assets

 

Tangible assets

4

167

333

Current assets

 

Debtors

5

16,894

32,827

Cash at bank and in hand

 

13,597

7,209

 

30,491

40,036

Creditors: Amounts falling due within one year

6

(299,047)

(351,226)

Net current liabilities

 

(268,556)

(311,190)

Net liabilities

 

(268,389)

(310,857)

Capital and reserves

 

Called up share capital

7

36

36

Profit and loss account

(268,425)

(310,893)

Shareholders' deficit

 

(268,389)

(310,857)

For the financial year ending 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 28 January 2022 and signed on its behalf by:
 

.........................................

Mr Barry Shrier
Director

 

Giant Health Events Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
GIANT Health
Health Foundry
1 Royal Street
London
SE1 7LL
United Kingdom

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

Over three years straight-line

 

Giant Health Events Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year was 3 (2020 - 2).

 

Giant Health Events Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2020

2,396

2,396

At 31 March 2021

2,396

2,396

Depreciation

At 1 April 2020

2,063

2,063

Charge for the year

166

166

At 31 March 2021

2,229

2,229

Carrying amount

At 31 March 2021

167

167

At 31 March 2020

333

333

5

Debtors

2021
£

2020
£

Trade debtors

10,794

19,500

Other debtors

6,100

13,327

16,894

32,827

6

Creditors

Creditors: amounts falling due within one year

2021
£

2020
£

Due within one year

Trade creditors

6,780

3,021

Accruals and deferred income

16,401

31,131

Other creditors

275,866

317,074

299,047

351,226

7

Share capital

Allotted, called up and fully paid shares

 

Giant Health Events Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

 

2021

2020

 

No.

£

No.

£

Ordinary of £0.00 each

36,294,594

36.29

36,294,594

36.29

         

8

Related party transactions

Summary of transactions with other related parties

During the year, the company paid consultancy fee of £8,756.45 +VAT (2020 £19,581.74 +VAT) to members of Barry Shrier's (the director) family. These family members included Christian Shrier, William Shrier, Venice Shrier and Annie Shrier. At the year-end date there were no outstanding amounts owed to any family member.